Gritstone Oncology, Inc. (GRTS) financial statements (2020 and earlier)

Company profile

Business Address 5858 HORTON STREET, SUITE 210
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments128153
Cash and cash equivalents5752
Short-term investments70101
Prepaid expense12
Other current assets00
Other undisclosed current assets22
Total current assets:131158
Noncurrent Assets
Operating lease, right-of-use asset23
Property, plant and equipment2729
Restricted cash and investments11
Other noncurrent assets 0
Other undisclosed noncurrent assets21
Total noncurrent assets:5332
TOTAL ASSETS:184190
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1010
Accounts payable55
Accrued liabilities11
Employee-related liabilities54
Deferred revenue5
Debt3 
Contract with customer, liability5
Other undisclosed current liabilities2 
Total current liabilities:2015
Noncurrent Liabilities
Long-term debt and lease obligation21 
Operating lease, liability21
Liabilities, other than long-term debt1015
Deferred revenue10
Contract with customer, liability13
Deferred rent credit 1
Other liabilities 0
Other undisclosed noncurrent liabilities 10
Total noncurrent liabilities:3125
Total liabilities:5040
Stockholders' equity
Stockholders' equity attributable to parent134149
Common stock00
Additional paid in capital355276
Accumulated other comprehensive income (loss)0(0)
Accumulated deficit(221)(126)
Total stockholders' equity:134149
TOTAL LIABILITIES AND EQUITY:184190

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Gross profit:41
Operating expenses(102)(67)
Operating loss:(98)(66)
Net loss:(98)(66)
Other undisclosed net income attributable to parent41
Net loss available to common stockholders, diluted:(94)(65)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(98)(66)
Comprehensive loss:(98)(66)
Other undisclosed comprehensive income, net of tax, attributable to parent41
Comprehensive loss, net of tax, attributable to parent:(94)(65)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: